Google Chrome
Safari
Firefox
Edge
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Search
Press Release / Sep 06, 2022
Hovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting
Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services.
Article / Apr 30, 2010
Inhalation: Going Beyond Asthma. Interview: Peter Villax and Jason Suggett
Drug Delivery Technology, April 2010
Press Clipping / May 03, 2023
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Analytical Characterization
Hovione advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Release / Mar 07, 2018
Hovione sells the iMAX business
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
Article / Sep 01, 2010
Bridging the Gap Between HAPI Production and Material Science
EPM Magazine, September 2010
Press Release / Oct 17, 2018
Hovione increases production capacity
‘One Site Shop’ expands to respond to growing demands
Press Release / May 03, 2023
Hovione and H&T Presspart extend partnership to advance high efficiency device technology for Dry Powder Inhalation formulation delivery
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.